Its 100 percent important that healthcare providers monitor people taking GLP-1s, says Horneff
Patients with diabetes, obesity, and existing atherosclerotic cardiovascular disease stand to benefit the most.
For eligible patients, Semaglutide GLP-1 injections offer a path toward better overall health, reduced weight, and a decreased risk of associated diseases, all while providing a well-tolerated and clinically proven treatment option
During the initial period of using any new transdermal medication, patients may experience local skin reactions such as mild redness, itching, or irritation at the application site
The long-term safety profile of GLP-1s is encouraging
Il nostro obiettivo aiutarti a stabilire e rafforzare il tuo posizionamento online